Richards Group Inc.

Richards Group Inc.

29.68
CAD
-0.12
(-0.40%)
2.28EPS
12.25P/E
303.26MMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
18.59
19.84
23.08
26.46
27.27
29.2
30.32
43.56
40.43
40.79
38.88
37.22
38.87
39.64
Basic EPS, GAAP
0.46
0.75
0.97
0.73
1.53
2.21
1.97
4.47
0.19
4.12
3.55
3.27
1.48
2.33
Free Cash Flow per Basic Share
1.81
1.27
1.21
3.05
2.72
2.09
3.47
6.38
4.88
3.54
7.35
4.49
3.29
4.24
Dividend per Share
0.86
0.94
0.97
1.16
1.38
1.43
1.41
1.37
1.38
2.1
1.77
1.75
1.36
1.33
Book Value per Share
7.28
7.72
9.23
8.61
8.43
10.03
11.28
14.3
11.94
14.74
16.44
18.63
19.02
19.95
Tangible Book Value per Share
-0.66
-0.34
-0.72
-0.96
-0.61
0.78
2.68
1.62
-0.83
1.88
3.78
5.37
2.71
0.88
Basic Weighted Avg Shares
11
11
11
11
11
11
11
11
11
11
11
11
11
11
Sales/Revenue/Turnover
199
212
249
287
297
318
334
489
451
447
426
408
430
443
Operating Margin (%)
6.57
9.34
10.8
11.84
12.52
13.47
13.18
19.06
14.82
12.87
13.09
13.58
10.14
11.55
Depreciation Expense
8
4
3
4
3
3
10
12
12
12
12
13
19
19
Net Income, GAAP
5
8
11
8
17
24
22
50
2
45
39
36
16
26
Effective Tax Rate (%)
40.88
42.16
43.31
56.23
41.63
33.16
34.34
31.45
89.71
23.9
27.98
28.5
41.06
32.72
Profit Margin (%)
2.5
3.78
4.21
2.75
5.61
7.58
6.5
10.25
0.46
10.11
9.13
8.79
3.81
5.87
Working Capital
29
29
44
33
26
35
39
38
10
83
57
55
76
94
LT Debt
36
32
47
42
33
27
52
66
57
94
46
32
81
120
Total Equity
78
83
100
93
92
109
127
161
131
162
180
204
217
212
Return on Invested Capital (%)
6.05
8.96
10.28
7.19
15.17
21.32
17.89
30.6
0.92
18.53
16.16
15.17
7.31
11
Return on Capital (%)
4.48
6.79
7.5
5.2
12.09
18.74
14.38
24.7
1.07
21.11
16.86
15.54
6.83
10.24
Return on Common Equity (%)
6.39
10
11.5
8.17
17.97
23.98
18.42
34.91
1.42
30.9
22.77
18.66
7.79
12.42

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
22
- -
- -
LT Borrowings
47
73
94
LT Finance Leases
35
29
26
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
11
11
11
Market Capitalization
353
314
303

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
166
167
169
Cash, Cash Equivalents & STI
6
5
9
Accounts Receivable, Net
49
52
53
Inventories
101
99
97
Total Current Liabilities
90
72
75
Payables & Accruals
65
72
75
ST Debt
22
- -
- -
Deferred Revenue
3
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.94%
7.23%
6.42%
Free Cash Flow
26.56%
-2.01%
-25.84%
Net Income, GAAP
216.4%
382.49%
-54.25%
Sales/Revenue/Turnover
6.49%
-2.44%
5.49%
Total Cash Common Dividend
5.36%
2.17%
-21.43%

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
98
107
98
105
408
2025
101
110
- -
111
430
2026
106
116
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.78
1.08
0.63
0.76
3.27
2025
0.45
0.32
- -
0.23
1.48
2026
0.53
1.26
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.72
0.34
0.34
0.33
1.75
2025
0.33
0.34
- -
0.33
1.36
2026
0.33
0.33
- -
- -
- -

Company Description

CEO
John Glynn
Full Time Employees
650
Sector
Process industries
Industry
Containers/Packaging
Address
6155 Belgrave Road Mississauga ON Canada L5R 4E6
IPO Date
Jan 18, 2006
Business
Richards Group Inc. operates as a Canadian value-added distributor and emerging original equipment manufacturer serving the healthcare and packaging markets. Founded in 1912 and headquartered in Mississauga, Ontario, the Company conducts operations principally through its Richards Health and Richards Packaging divisions, serving healthcare providers, pharmacies, retailers, manufacturers, and small and medium-sized commercial customers in Canada, the United States and international markets. Richards Health distributes medical devices, capital equipment, consumable products, supplies and related solutions for aesthetic medicine, pharmacy, vision care, surgical and dental applications; provides pharmacy equipment, systems and supplies; and develops, owns and markets healthcare products under the DermapenWorld, Dispill, LUVO and WorldPRP brands. The division operates through specialized businesses including Clarion Medical Technologies and Healthmark Services Ltd. Richards Packaging, operating under the Richards Packaging and McKernan Packaging brands, distributes glass, plastic and specialty rigid packaging products, including bottles, jars, containers, closures and related packaging solutions for food and beverage, cosmetics and personal care, pharmaceutical, industrial and other end markets across North America. The Company emphasizes product innovation, high-touch customer service, technical expertise, acquisition-led expansion and modernization of its operating infrastructure. In December 2025, Richards Packaging Income Fund completed its conversion from an open-ended income trust to Richards Group Inc., with common shares commencing trading on the Toronto Stock Exchange under the symbol RIC. Recent healthcare expansion includes the February 2025 acquisitions of National Dental Innovations and HL Production, the June 2025 acquisition of DermapenWorld, and the May 2026 acquisition by Healthmark Services Ltd. of the consumer packaged goods assets of PharmaSystems Inc. for $13.5 million, adding over-the-counter health and wellness products supplied to major Canadian pharmacies and retailers.

Company News